Risk of business activity and economic stagnation due to the spread of COVID-19
First written in FY2020. 9 of 11 entries say "Restated". Latest entry: FY2024.
Nomura Micro Science moved to the "Worse" side of this theme in 2024, 4 years after the typical company in this theme (2020).
1 other company's latest entry also says "Softened".
- FY2024SoftenedAnnual report
「Although there was no significant impact from COVID-19 as of the end of the current consolidated fiscal year, actual results may differ if further spread of the infection causes economic activity to stagnate.」
It was explained that, as of the end of the current period, there was no significant impact from COVID-19, reducing its prominence as a standalone key risk compared with before. - FY2023-Q2RestatedAnnual report
「The spread of COVID-19 is affecting economic activity worldwide. However, as of the present time, the impact on the activities of our Group from the third quarter onward is judged to be minor, and accounting estimates, including the assessment of the recoverability of deferred tax assets, are being made. Although the impact on the consolidated financial statements from the third quarter onward is considered to be minor, if further spread of the infection causes economic activity to stagnate, this may affect the performance of our Group.」
While judging the impact from the third quarter onward to be minor, the possibility of economic stagnation and an impact on performance caused by further spread of the infection continues to be disclosed. - FY2023-Q1RestatedAnnual report
「The spread of COVID-19 is affecting economic activity worldwide. However, as of the present time, the impact on the activities of our Group from the second quarter onward is judged to be minor, and accounting estimates, including the assessment of the recoverability of deferred tax assets, are being made. Although the impact on the consolidated financial statements from the second quarter onward is considered to be minor, if further spread of the infection causes economic activity to stagnate, this may affect the performance of our Group.」
While judging the impact from the second quarter onward to be minor, the possibility of economic stagnation and an impact on performance caused by further spread of the infection continues to be disclosed. - FY2022RestatedAnnual report
「At this time, no significant impact on performance from the spread of COVID-19 or the situation in Russia and Ukraine was observed.」
While stating that no significant impact on performance for the current period was observed, the possibility of a future impact on performance from the spread of infection and economic stagnation, among other factors, continues to be monitored. - FY2022-Q3RestatedAnnual report
「Although the global spread of COVID-19 has affected economic activity worldwide, the company has judged, as of the present time, that the impact on the group’s activities from the fourth quarter onward will be minor and has made accounting estimates, including judgments regarding the recoverability of deferred tax assets. In this case, the company believes that the impact on the consolidated financial statements from the fourth quarter onward will be minor, but if further spread of the infection causes economic activity to stagnate, it could affect the performance of the group.」
While judging the impact on activities from the fourth quarter onward and on the consolidated financial statements to be minor, the possibility of economic stagnation and an impact on performance caused by further spread of the infection continues to be disclosed. - FY2022-Q2RestatedAnnual report
「Although the global spread of COVID-19 has affected economic activity worldwide, the company has judged, as of the present time, that the impact on the group’s activities from the third quarter onward will be minor and has made accounting estimates, including judgments regarding the recoverability of deferred tax assets. In this case, the company believes that the impact on the consolidated financial statements from the third quarter onward will be minor, but if further spread of the infection causes economic activity to stagnate, it could affect the performance of the group.」
While judging the impact on activities from the third quarter onward and on the consolidated financial statements to be minor, the possibility of economic stagnation caused by further spread of the infection continues to be disclosed. - FY2021RestatedAnnual report
「During the consolidated fiscal year, no material impact on performance from the spread of COVID-19 was observed.」
While stating that no material impact on performance for the current fiscal year was observed, the company continued to disclose the possibility that further spread of the infection could cause economic activity to stagnate and affect performance. - FY2021-Q3RestatedAnnual report
「Although the global spread of COVID-19 has affected economic activity worldwide, the company has judged, as of the present time, that the impact on the group’s activities from the fourth quarter onward will be minor and has made accounting estimates, including judgments regarding the recoverability of deferred tax assets. In this case, the company believes that the impact on the consolidated financial statements from the fourth quarter onward will be minor, but if further spread of the infection causes economic activity to stagnate, it could affect the performance of the group.」
While judging that the impact on performance and accounting estimates from the fourth quarter onward would be minor, the company continued to disclose the possibility of economic activity stagnating due to further spread of the infection as a risk. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, no material impact on performance from the spread of COVID-19 was observed.」
The company stated that no material impact on performance from the spread of the infection was observed during the cumulative second quarter. Meanwhile, it made accounting estimates based on a judgment that the impact from the third quarter onward would be minor, while continuing to disclose the potential for further spread of the infection to affect performance. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, no material impact on performance from the spread of COVID-19 was observed.」
While stating that the spread of COVID-19 had no material impact on performance for the quarter, the company judged the impact from the second quarter onward to be minor in its accounting estimates and continued to disclose the potential for further spread of the infection to affect performance. - FY2020First statedAnnual report
「During the consolidated fiscal year, trial operations for some customers in China were postponed due to the spread of COVID-19, but no material impact on performance was observed. No material impact on performance from the spread of COVID-19 has been observed as of the present time, but if further spread leads to economic activity stagnating, it could affect the performance of the group.」
While trial operation postponements had already occurred for some customers in China, the company stated that there was no material impact on performance for the current fiscal year. It disclosed for the first time, as a standalone risk, the potential for further spread of the infection to stagnate economic activity and affect performance.